Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by country, state, or city

Search by locations

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “United Kingdom”

An Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) for Pulmonary Arterial Hypertension (PAH)Active Not Recruiting
NCT05649748Phase 2, Phase 3Updated Aug 20, 2026
Sponsor: Insmed Incorporated
Pulmonary Arterial Hypertension
United States, Argentina, Austria, Belgium, Brazil +10 more
Pivotal Study of N-acetyl-L-leucine for CACNA1ARecruiting
NCT07221292Phase 3Updated Aug 20, 2026
Sponsor: IntraBio Inc
CACNA1A · Spinocerebellar Ataxia Type 6 · Episodic Ataxia Type 2 · Familial Hemiplegic Migraine-1
United States, Austria, Germany, Greece, Italy +2 more
Efficacy and Safety of Vamifeport in Adult Participants With Homeostatic Iron Regulator Gene (HFE)-Related Hereditary HemochromatosisRecruiting
NCT07332091Phase 2Updated Aug 20, 2026
Sponsor: CSL Behring
Homeostatic Iron Regulator Gene-related Hereditary Hemochromatosis
United States, Australia, Austria, Belgium, Canada +13 more
A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's DiseaseRecruiting
NCT06819878Phase 3Updated Aug 20, 2026
Sponsor: Hoffmann-La Roche
Moderately to Severely Active Crohns Disease
United States, Argentina, Australia, Austria, Belgium +33 more
Total Shoulder Arthroplasty Multi-Center RegistryRecruiting
NCT03511586N/AUpdated Aug 20, 2026
Sponsor: Arthrex, Inc.
Shoulder Arthroplasty
United States, Germany, Switzerland, United Kingdom
Chemotherapy and Maximal Tumor Debulking of Multi-organ Colorectal Cancer MetastasesActive Not Recruiting
NCT01792934NAUpdated Aug 20, 2026
Sponsor: Radboud University Medical Center
Multi-organ Metastatic Colorectal Cancer
Netherlands, United Kingdom
Radiotherapy Plus Xevinapant in Older Patients With Locally Advanced Head and Neck Squamous Cell CarcinomaTerminated
NCT05724602Phase 2Updated Aug 20, 2026
Sponsor: European Organisation for Research and Treatment of Cancer - EORTC
Locally Advanced Head and Neck Squamous Cell Carcinoma
Belgium, France, Germany, Ireland, Italy +5 more
A Clinical Study to Evaluate Ianalumab in Participants With Diffuse Cutaneous Systemic SclerosisRecruiting
NCT06470048Phase 2Updated Aug 19, 2026
Sponsor: Novartis Pharmaceuticals
Diffuse Cutaneous Systemic Sclerosis
United States, Argentina, Austria, Belgium, Brazil +20 more
Phase 3 Study of T-DXd and Rilvegostomig Versus SoC in Advanced HER2-expressing Biliary Tract CancerRecruiting
NCT06467357Phase 3Updated Aug 19, 2026
Sponsor: AstraZeneca
Biliary Tract Cancer
United States, Australia, Austria, Belgium, Brazil +22 more
A Study to Investigate the Safety and Efficacy of Belantamab for the Treatment of Multiple Myeloma When Used as Monotherapy and in Combination TreatmentsRecruiting
NCT05714839Phase 1, Phase 2Updated Aug 19, 2026
Sponsor: GlaxoSmithKline
Multiple Myeloma
United States, Argentina, Australia, Brazil, China +8 more
BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer Who Have Not Received Prior Treatment for Advanced or Metastatic DiseaseRecruiting
NCT07492641Phase 3Updated Aug 19, 2026
Sponsor: BeOne Medicines
HR+/HER2- Breast Cancer
United States, Australia, Brazil, China, Japan +5 more
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular DiseaseRecruiting
NCT07181109Phase 3Updated Aug 19, 2026
Sponsor: Alnylam Pharmaceuticals
High Risk Cardiovascular Disease · Hypertension · High Cardiovascular Risk
United States, Argentina, Australia, Austria, Belgium +29 more
An Agentic Co-educator System for Personalized Medical EducationCompleted
NCT06759012NAUpdated Aug 19, 2026
Sponsor: Tsinghua University
Medical Education
Australia, China, Ghana, India, Malaysia +1 more
Effects of Obesity on Autophagy and mTORC1 Signalling in Skeletal MuscleRecruiting
NCT07774676N/AUpdated Aug 19, 2026
Sponsor: University of Birmingham
Overweight and Obese Adults
United Kingdom
OptiMuscle - Improving Respiration by Optimising Muscle FunctionRecruiting
NCT06103955NAUpdated Aug 19, 2026
Sponsor: University of Salford
Dysfunctional Breathing · Breathing Pattern Disorder
United Kingdom
EF-41/KEYNOTE D58: Phase 3 Study of Optune Concomitant With Temozolomide Plus Pembrolizumab in Newly Diagnosed GlioblastomaRecruiting
NCT06556563Phase 3Updated Aug 19, 2026
Sponsor: NovoCure GmbH
Glioblastoma
United States, Canada, Czechia, France, Germany +7 more
A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)Recruiting
NCT07221500Phase 2Updated Aug 19, 2026
Sponsor: Nurix Therapeutics, Inc.
Chronic Lymphocytic Leukemia (CLL) · Small Lymphocytic Lymphoma (SLL)
United States, France, Italy, Poland, United Kingdom
A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)Recruiting
NCT06937229Phase 3Updated Aug 19, 2026
Sponsor: Bristol-Myers Squibb
Alzheimer Disease · Agitation
United States, Argentina, Brazil, Bulgaria, Canada +21 more
Real World Data Collection in Subjects Treated With the FARAPULSE Pulsed Field Ablation SystemActive Not Recruiting
NCT05501873N/AUpdated Aug 19, 2026
Sponsor: Boston Scientific Corporation
Atrial Fibrillation
Australia, Austria, Belgium, Czechia, Finland +16 more
A Study of Orforglipron (LY3502970) Compared With Dulaglutide in Pediatric Participants With Type 2 DiabetesNot Yet Recruiting
NCT07668336Phase 3Updated Aug 19, 2026
Sponsor: Eli Lilly and Company
Diabetes Mellitus, Type 2
United States, Belgium, Brazil, India, Italy +6 more
A Study of Zanubrutinib Plus Anti-CD20 Versus Lenalidomide Plus Rituximab in Participants With Relapsed/Refractory Follicular or Marginal Zone LymphomaActive Not Recruiting
NCT05100862Phase 3Updated Aug 19, 2026
Sponsor: BeOne Medicines
Relapsed/Refractory Follicular Lymphoma · Marginal Zone Lymphoma
United States, Argentina, Australia, Austria, Belgium +23 more
CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) AmyloidosisRecruiting
NCT07207811Phase 3Updated Aug 19, 2026
Sponsor: Novo Nordisk A/S
Transthyretin Amyloid Cardiomyopathy (ATTR CM)
United States, Argentina, Australia, Belgium, Brazil +15 more
Study to Investigate Efficacy, Safety, and Tolerability of Zibotentan/Dapagliflozin Compared to Dapagliflozin in Participants With Chronic Kidney Disease and High Proteinuria (ZENITH High Proteinuria)Active Not Recruiting
NCT06087835Phase 3Updated Aug 19, 2026
Sponsor: AstraZeneca
Chronic Kidney Disease With High Proteinuria
United States, Argentina, Australia, Austria, Brazil +25 more
A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Nephropathy (IgAN)Recruiting
NCT06935357Phase 3Updated Aug 19, 2026
Sponsor: Biogen
Immunoglobulin A Nephropathy (IgAN)
United States, Argentina, Australia, Belgium, Brazil +23 more
Study of Efficacy and Safety of Tisagenlecleucel in HR B-ALL EOC MRD Positive PatientsActive Not Recruiting
NCT03876769Phase 2Updated Aug 19, 2026
Sponsor: Novartis Pharmaceuticals
B-Cell Acute Lymphoblastic Leukemia
United States, Belgium, Canada, Denmark, France +6 more

Previous page Next page